The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...

The Food and Drug Administration (FDA) recently gave approval for clinical trials in the U.S. of a COVID-19 nasal vaccine ...

Researchers at Cornell University's Weill Medical College in New York have created a successful vaccine strategy in mice that uses ... aeruginosa to the capsid shell of a replication-deficient ...

An inhalable version of a single-shot, adenovirus-based viral vector vaccine might provide a new option for COVID-19 vaccination. In October 2021, the World Health Organization set a target for ...

In some cases, no reformulation was required; the intramuscular vaccine could simply be aerosolized into a spray. This applies to adenovirus-vectored vaccines, which feature replication-deficient cold ...

AstraZeneca said it was exploring combinations of different adenovirus vaccines to find out whether mixing them leads to a better immune response and, therefore, greater protection. The hope is ...

Editor’s note: The Covid-19 Vaccine Frequently Asked Questions page has been retired. Updated information regarding Covid-19 vaccination may be found at the NEJM Covid-19 Vaccine Resource Center.

OCAS announced today that it will be holding two events to offer the opportunity to get their pets vaccinated and microchipped at no cost.

A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...